Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Design, Synthesis, Anti-Oomycete, and Insecticidal Activities of 3β-Acyloxy-18β-Glycyrrhetinic Acid Derivatives.

Created on 25 Oct 2025

Authors

Shaobin Xu, Jiaxuan He, Genqiang Chen, Xiaobo Huang, Yuee Tian, Zhiping Che

Published in

Chemistry & biodiversity. Pages e02978. Oct 24, 2025. Epub Oct 24, 2025.

Abstract

18β-Glycyrrhetinic acid (GA) is a pentacyclic triterpenoid compound mainly extracted from the roots of the leguminous plant licorice. To discover botanical pesticides, twelve 3β-acyloxy-18β-glycyrrhetinic acid derivatives (3a-l) were synthesized, and their structures were characterized by 1H NMR, 13C NMR, and HR-MS. In addition, we assessed the bioactivities of these title compounds as anti-oomycete and insecticidal agents against two serious agricultural pests, Phytophthora capsici and Mythimna separata. Amongst all tested target compounds, (1) Six compounds 3d, 3e, 3h, 3i, 3j, and 3k indicated promising anti-oomycete activity against P. capsici, with EC50 values of 28.27, 29.36, 23.88, 20.03, 23.07, and 25.93 mg/L, respectively. (2) Six compounds showed significant insecticidal activity, the final mortality rates of 3b, 3c, 3f, 3g, 3i, and 3l were 66.7%, 55.6%, 63.0%, 60.7%, 51.9%, and 75.6%, respectively. The anti-oomycete and insecticidal activities of the title compounds were closely related to R, which has a significant impact on its activity.

PMID:
41135017
Bibliographic data and abstract were imported from PubMed on 25 Oct 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 50
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement